We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Associated Press

Johnson & Johnson ordered to pay €47 million over talc powder link to cancer

The company faces more than 1,000 other talc-cancer lawsuits.

Updated 12pm. 

JOHNSON & JOHNSON has been ordered to pay €47.6 million to a woman who said the company’s talc powder caused her to develop ovarian cancer.

A jury in the US city of St. Louis returned the verdict on Monday.

The 62-year-old South Dakota woman had been using J&J’s talc-based feminine hygiene products for almost 40 years before being diagnosed with cancer in 2011.

J&J, which is the world’s largest maker of health-care products, is facing around 1,200 lawsuits for not warning customers of studies linking some of its products to ovarian cancer.

Bloomberg reports that the company also lost a €62 million verdict in the same St Louis courthouse to the family of a woman who died of the disease.

It’s reported that J&J plans to appeal the verdict.


In its natural form talc contains asbestos which is generally accepted as being able to cause cancer if it’s inhaled.

However, the American Cancer Society states that “all talcum products used in homes in the United States have been asbestos-free since the 1970s”.

In 2013, a study which pooled the results of eight research papers found an increased risk of ovarian cancer of between 20% and 30% for women who used talc for intimate personal hygiene.

The study, which was carried out on 2,000 women, did not find a direct link between how much talc was used and the risk of cancer.

It is also suggested that talcum powder might cause cancer in the ovaries if the powder particles travel through the vagina, uterus and fallopian tubes to the ovary.

However, the American Cancer Society states that, “For any individual woman, if there is an increased risk, the overall increase is likely to very be small.”

Read: Irish student whose mother had breast cancer is researching new ways to identify the disease>

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Your Voice
Readers Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.